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Abstract
Background: Cancer is a leading cause of mortality and morbidity worldwide. Prevention is recognised by many,
including the World Health Organization, to offer the most cost-effective long-term strategy for the control of cancer.
One approach that focuses on individuals is the provision of personalised risk information. However, whether such
information motivates behaviour change and whether the effect is different with varying formats of risk presentation is
unclear. We aim to assess the short-term effect of providing information about personalised risk of cancer in three
different formats alongside lifestyle advice on health-related behaviours, risk perception and risk conviction.
Methods: In a parallel group, randomised controlled trial 1000 participants will be recruited through the online
platform Prolific. Participants will be allocated to either a control group receiving cancer-specific lifestyle advice alone
or one of three intervention groups receiving the same lifestyle advice alongside their estimated 10-year risk of
developing one of the five most common preventable cancers, calculated from self-reported modifiable behavioural
risk factors, in one of three different formats (bar chart, pictograph or qualitative scale). The primary outcome is change
from baseline in computed risk relative to an individual with a recommended lifestyle at three months. Secondary
outcomes include: perceived risk of cancer; anxiety; cancer-related worry; intention to change behaviour; and
awareness of cancer risk factors.
Discussion: This study will provide evidence on the short-term effect of providing online information about
personalised risk of cancer alongside lifestyle advice on risk perception and health-related behaviours and inform the
development of interventions.
Trial registration: ISRCTN17450583. Registered 30 January 2018.
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Background
Cancer is now a leading cause of mortality and morbid-
ity worldwide [1]. Prevention is recognised by many, in-
cluding the World Health Organisation [2], to offer the
most cost-effective long-term strategy for the control of
cancer. It is estimated that approximately 40% of cases
of cancer are attributable to lifestyle factors including
smoking, diet, alcohol consumption, physical activity
and weight [3]. Prevention strategies targeting these be-
haviours are likely to require a combination of collective
approaches aimed at shifting the population distribution
and approaches that focus on individuals.
One element of approaches that focus on individuals
is the provision of risk information. Many behaviour
change theories suggest that to engage in risk-reducing
behaviour, individuals must believe that they are at risk
[4, 5]. Although evidence for behaviour change following
* Correspondence: jau20@medschl.cam.ac.uk
1The Primary Care Unit, Institute of Public Health, University of Cambridge
School of Clinical Medicine, Box 113 Cambridge Biomedical Campus,
Cambridge CB2 0SR, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Usher-Smith et al. BMC Public Health  (2018) 18:796 
https://doi.org/10.1186/s12889-018-5712-2
provision of risk information in general is limited [6–8],
in a recent systematic review of randomised controlled
trials of the effect of interventions incorporating perso-
nalised non-genetic cancer risk information on inten-
tions and behaviour [9], we found only one study that
reported the effect on smoking status [10] and none
assessing the impact on diet, physical activity and alco-
hol consumption. The impact of cancer risk information
on lifestyle behaviour is, therefore, not known.
Additionally, while it has been demonstrated that pro-
viding individuals with information about their risk of
cancer can improve accuracy of risk perception [11–13],
studies have tended to focus on risk perception as a de-
liberative, reason-based concept. More recent work has
highlighted the distinction between deliberative, affective
and experiential risk perceptions [14, 15]. Instead of be-
ing driven by probability judgments or deliberation,
affective risk perceptions reflect an emotional response
to a threat, such as fear or worry, and experiential risk
perceptions involve “gut-level reactions” based on
learned associations [15]. A tripartite model (TRIRISK)
including these three components has recently been de-
veloped, and confirmatory factor analyses have shown it
to provide a better fit to the data than either dual-factor
or single-factor models [15]. Distinguishing in this way
between deliberative, affective, and experiential risk per-
ceptions therefore has the potential to provide greater
insights into associations between risk perception and
behaviour change. No studies have yet been published in
which these three components have been measured fol-
lowing the provision of risk information.
Risk conviction, the certainty and clarity with which a
risk perception is held, is also an emerging concept
which has been proposed as a moderator of the relation-
ship between risk perception and subsequent behaviour
change [16]. For example, conceivably individuals who
have a perception of high disease risk but who feel un-
certain about this judgement, may be less motivated to
engage in health promoting behaviours.
A further factor that may influence risk perception is
the format in which risk is presented. There are over
2000 ways to present risk information [17]. While some
studies have found no clear preference amongst partici-
pants on which should be used [18–21], some formats
have been reported to have greater impact on accuracy
or level of risk perception than others. For example, nu-
merical presentation of risk as opposed to simple risk
categories appears to lead to more accurate risk percep-
tion [22]; displaying risk information visually can en-
hance understanding compared with written information
alone, particularly amongst those with low numeracy
[23]; and pictographs are understood and interpreted
with the greatest accuracy due to their clear display of
the reference population to which the individual belongs
[24, 25]. Presenting risk as a relative risk reduction also
appears to be the most effective format for encouraging
uptake of treatment [22], although this may be a func-
tion of the relative risk being confused for absolute risk.
Presenting information about cancer risk in different for-
mats may therefore result in different effects both on
risk perception and behaviour.
In this parallel group, randomised controlled trial we
aim to assess the short-term effect of providing informa-
tion about personalised risk of cancer in three different
formats alongside lifestyle advice on health-related be-
haviours, risk perception and risk conviction.
Objectives
Primary objective
The primary objective is to evaluate the effect of provid-
ing different formats of personalised cancer risk infor-
mation based on self-reported modifiable behaviour risk
factors alongside lifestyle information on change from
baseline in computed risk relative to an individual with a
recommended lifestyle at three months.
Secondary objectives
The secondary objectives are to evaluate the effect of
providing different formats of personalised cancer risk
information alongside lifestyle information on: perceived
risk of cancer; anxiety; cancer-related worry; intention to
change behaviour; and awareness of cancer risk factors.
Methods
Study design
The trial is a parallel group, randomised controlled trial
with participants allocated to either a control group
which receives cancer-specific lifestyle advice alone or
one of three intervention groups which receive the same
lifestyle advice alongside their estimated 10-year risk of
developing one of the five most common preventable
cancers in one of three different formats (bar chart,
pictograph, qualitative scale). The design of the trial and
flow of participants are shown in Fig. 1.
Population and recruitment
We aim to recruit 1000 men and women between 30
and 74 years of age resident in the UK without a past
history of cancer and with an approval rating ≥ 95% [26]
using the Prolific platform (https://www.prolific.ac/).
Prolific is an online participant recruitment platform for
researchers in which participants volunteer to take part
in studies and are compensated for their time with an
agreed hourly rate. On 22 February 2018 there were
6245 participants registered with Prolific who met our
inclusion criteria.
Eligible participants will be emailed an invitation to
take part in the study by Prolific. If they are interested in
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taking part they will then be directed to the participant
information sheet (Additional file 1) and have the oppor-
tunity to take part in the study or contact the research
team for further information. They will be paid £2 for
completing the baseline assessment and intervention
and £1 for the follow-up 3 months later (the equivalent
of £6/h). This will be paid through Prolific.
Setting
The trial is online and led from the University of
Cambridge. Participants are resident within the UK.
Consent
Written online consent will be obtained from each par-
ticipant at the start of the study and again at the begin-
ning of the three month follow-up data collection.
Baseline assessment
All baseline information will be collected prior to ran-
domisation. After completing the electronic consent,
participants will be directed to a baseline online ques-
tionnaire. This includes questions about age, sex, and
current lifestyle (see below for details) to allow calcula-
tion of the individual’s cancer risk. The questions re-
quired for that calculation are compulsory. All other
questions are optional. An instructional manipulation
check is also included in the baseline questionnaire to
identify inattentive participants and increase the validity
and reliability of the responses [27–29]. This takes the
form of a single question “It is important that you pay
attention in this study. Please tick ‘Strongly Disagree’.”
Participants who fail to answer the question correctly
will be excluded from the study prior to randomisation.
Randomisation, allocation concealment and blinding
The baseline questionnaires and all study materials will
be developed within the Gorilla.sc research platform
(www.gorilla.sc/about). Gorilla is a bespoke software
program that allows researchers to develop online ques-
tionnaires and interactive tasks. Participants will be ran-
domised 1:1:1:1 to the four groups at an individual level
using a computer program built into the Gorilla research
platform based on computer generated random numbers
within block sizes of eight. Randomisation will be strati-
fied by sex, risk relative to an individual with a recom-
mended lifestyle (≤ or > 1.5) and age (≤ or > 40 years).
Given the nature of the trial, it is not possible to blind
participants to which intervention they receive. The re-
searchers assessing the trial outcomes will remain
blinded to the allocation of individuals until generation
of the final dataset for analysis.
Interventions
Participants in all four groups will be provided with tai-
lored lifestyle advice. The three intervention groups will
additionally be provided with a personalised estimate of
Fig. 1 CONSORT diagram
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their risk of developing cancer in one of three formats
and have the opportunity to see the impact on their esti-
mated risk of changes that they could make to their life-
style. The control group will receive generic information
about the link between lifestyle and cancer.
Lifestyle advice
All participants will be provided with links to web-based
information on how to reduce risk of cancer through
changes in lifestyle. This will include generic information
about setting goals and obtaining support alongside spe-
cific information on each of the key target behaviours
(quitting smoking, losing weight, reducing alcohol con-
sumption, eating more fruit and vegetables, eating less
red and processed meat and being more active). The
links to these pages will be tailored so that individuals
only see information relevant to them, for example
non-smokers will not be provided with a link to infor-
mation on smoking cessation. Each page relating to the
target behaviours will include details of the association
with cancer, the recommended daily or weekly amount,
ideas about how to make changes, and a space for goal
setting and action planning (see Additional file 2 for an
example). Participants will be able to print each page
separately for future reference. Clicking on all the links
to the lifestyle information is not a requirement for com-
pletion of the trial. However, if a participant attempts to
leave the page without viewing any lifestyle information
a pop-up will appear saying “You have not viewed any of
the lifestyle pages. You will not be able to return to this
page. Are you sure you want to leave?”. A similar
pop-up will appear reminding all participants that they
will not be able to return to the lifestyle pages once they
leave.
Risk estimates
The 10-year risk of developing one or more of the top
five preventable cancers (lung, colorectal, bladder, kidney
and oesophageal cancer for men and breast, lung, colo-
rectal, endometrial and kidney cancer for women) will
be estimated for each participant using a lifestyle-based
risk score developed for this purpose. Full details of the
development and validation of the model will be pub-
lished separately. In brief, lifestyle factors for each cancer
were selected from the European Code against Cancer
4th Edition [30–34] and estimates of relative risks ob-
tained from meta-analyses of observational studies.
Average population values of each risk factor in ten year
age groups were obtained from nationally representative
samples [35, 36] and mean 10-year estimated absolute
risks from routinely available sources [37, 38]. Together
these allowed us to calculate for each individual the ab-
solute 10-year estimated risk and the 10-year risk rela-
tive to an average person of the same age and sex. To
enable us to present estimates of the change in risk if in-
dividuals followed a “recommended” lifestyle, we also
calculated the risk for each sex and ten year age group
with recommended values of the risk factors. For smok-
ing, body mass index (BMI, calculated as weight (kg) di-
vided by the square of the height (m)), fruit and
vegetable consumption and physical activity, we used the
UK Department of Health guidelines to define these [39,
40] (being a non-smoker, having a BMI of 25 kg/m2, eat-
ing five portions of fruit and vegetables a day, and doing
150 min of moderate physical activity per week). For al-
cohol and red and processed meat consumption which
are associated with increased risk, we used zero as our
recommended level in line with recommendations from
the World Cancer Research Fund [41]. This decision
was made to avoid appearing to encourage consumption
of red or processed meat or alcohol among those con-
suming small amounts.
The risk score included age, sex, BMI, fruit, vegetable,
red meat and processed meat consumption, alcohol in-
take and physical activity. These were all obtained from
participants’ responses in the baseline questionnaire.
Formats of risk presentation
In order to assess the effect of absolute and/or relative
risk and numerical and/or verbal descriptions of risk,
the three intervention groups will see their personalised
risk estimate in one of three formats (Fig. 2). The first is
a bar chart showing the risk for people with their
current lifestyle compared to the risk for people of their
age and sex who follow the recommended lifestyle, with
estimates of absolute risk provided as percentages above
each of the bars. The second is pictographs first showing
the estimated absolute risk of people with their current
lifestyle and then the difference between that and the ab-
solute risk of people of their age and sex who follow a
recommended lifestyle. To enable visualisation of the
difference for those participants with a low absolute risk,
those with an absolute risk > 8% are shown a 100 icon
pictograph and those with a relative risk ≤8% a 1000
icon pictograph with a magnified section of 100 icons.
The third provides qualitative information on a scale
from “Below average” to “Above average” on the risk first
for people with their current lifestyle compared to an
average person of the same age and sex and then the risk
for people of their age and sex who follow a recom-
mended lifestyle compared to an average person of the
same age and sex.
All three groups are then able to set target values for
each of the lifestyle elements and see the impact of this
on the risk estimates. They are unable to proceed to
the next part of the trial without completing this step
but can click back and forth to amend their target
values and observe the effect on their risk estimate as
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many times as they wish. They can then print a sum-
mary of the risk estimates with their target values
included.
Post-intervention assessment
Immediately after viewing the lifestyle information or
lifestyle information and risk presentation participants
will be directed to complete a second online question-
naire. They will have a maximum of 45 min from pro-
viding initial consent to complete this. Approximately
three months post-intervention, participants will be con-
tacted through Prolific and invited to complete a final
online questionnaire. On completion of that question-
naire those participants who were in the lifestyle advice
only group will be given the opportunity to view their
estimated risk and see in the impact of changes in life-
style as for group two (bar chart presentation).
Measures
The measures collected and the stage of the trial at
which each is assessed are shown in Table 1. The pri-
mary outcome is change from baseline to three months
in risk relative to an individual with a recommended life-
style calculated from self-report data using the risk score
described above. Participants have the option to enter
height and weight in metric (m and kg) or imperial (feet
and inches and stone and pounds) measures. Fruit and
vegetable consumption are estimated from two ques-
tions: “How many portions of fruit/vegetables do you eat
on a typical day?”. Each question is accompanied by im-
ages and descriptions of the rough equivalent of one
portion for a range of fruit or vegetables. Red meat and
processed meat consumption are collected using similar
questions covering a typical week, again with images of a
portion for a range of examples. Alcohol intake is
Fig. 2 Risk presentation formats. (a) Bar chart; (b) 100 icon pictograph for those with an absolute risk > 8%; (c) 1000 icon pictograph with a
magnified section of 100 icons for those with a relative risk ≤8%; (d) qualitative scale
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assessed using the question “How many units of alcohol
do you drink in a typical week?” with the number of
units in a typical pint of beer or cider, a bottle of beer, a
small or large glass of wine and a shot of spirits pro-
vided. Physical activity is estimated from responses to
the question “How many hours of physical activity such
as brisk walking, cycling, keep fit, aerobics, swimming or
jogging, do you do in a typical week?”. Current and
ex-smokers were identified from responses to the ques-
tion “Do you currently smoke?” (Yes, No, No but I used
to). Participants are not able to leave these questions
blank. To improve the accuracy of responses to these
questions a warning box appears alerting participants if
their BMI is outside the range 12 to 50 kgm− 2 or if they
have entered free text into any of the questions requiring
a number. Participants then have the opportunity to cor-
rect their responses at that stage. This same check ap-
plies when data on these variables are collected at the
three-month follow-up.
All secondary outcomes and potential moderators and
mediators are also measured via self-report. Perceived
risk is measured using the tripartite risk perception
(TRIRISK) model [15] which includes deliberative,
affective and experiential components of perceived risk.
Table 1 List of outcome measures at each time point in the trial
Measure Baseline Immediately post intervention 3 months post intervention
Demographics
Age ✓ – –
Sex ✓ – –
Ethnicity ✓ – –
Family history of cancer ✓ – –
Highest education level ✓ – –
Lifestyle
Self-reported weight ✓ – ✓
Self-reported height ✓ – –
Smoking status (current/ex-smoking/never smoker) ✓ – ✓
Alcohol consumption (units per week) ✓ – ✓
Physical activity (hours per week) ✓ – ✓
Fruit consumption (portions per day) ✓ – ✓
Vegetable consumption (portions per day) ✓ – ✓
Red meat consumption (portions per week) ✓ – ✓
Processed meat consumption (portions per week) ✓ – ✓
Secondary outcome measures
Awareness of cancer risk factors ✓ ✓ ✓
Risk perception ✓ ✓ ✓
Risk conviction ✓ ✓ ✓
Self-efficacy – ✓ –
Response-efficacy – ✓ –
Maladaptive coping ✓ ✓ ✓
Intention to change behaviour – ✓ –
Worry (Lerman cancer worry scale) ✓ – ✓
Anxiety (short-item SSAI) ✓ ✓ ✓
Potential mediators and moderators
Numeracy ✓ – –
Time orientation ✓ – –
Self-rated general health ✓ – –
Previous information on risk of developing cancer ✓ – –
Cognitive evaluation of provision of cancer risk scores:
Acceptability/usefulness etc. of information – ✓ –
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After questions about both absolute and comparative
risk, we will also collect data on risk conviction using
two questions (‘How certain are you about your answer
to the above question / How confident are you that the
estimate you gave in response to [the question above] is
accurate, that is, that it reflects your actual risk?’) on
7-point Likert response scales from 1 (Not at all certain
/ Not at all confident) to 7 (Extremely certain /
Extremely confident). These questions are included to
allow assessment of whether risk conviction improves
how well the construct of perceived risk predicts behav-
iour. They are adapted from suggestions in the literature
[16] and are currently also being tested in a study in the
US (personal report).
We will also collect data on cancer-related worry and
anxiety using the Lerman cancer worry scale [42, 43]
and the short-form of the state scale of the Spielberger
State Trait Anxiety Inventory (STAI) [44] respectively.
The Lerman cancer worry scale has been widely used in
the literature [45, 46] and the short-form STAI consists
of 6 items that comprise the most highly correlated state
anxiety-present and state anxiety-absent items from the
full-form of the STAI. Scores obtained using this
short-form have been shown to be highly correlated with
scores obtained using the full-form of the STAI [44].
Maladapative behaviours will be assessed using three
statements adapted from Rippetoe and Rogers [47] and
awareness of cancer risk factors using question six from
the Cancer Awareness Measure [48].
Overall intention to change behaviour will be mea-
sured immediately post intervention using four ques-
tions on 7-point Likert response scales from 1 (Strongly
disagree) to 7 (Strongly agree) as in Ferrer et al., [15] (‘I
am determined to do everything I can to avoid getting
cancer in the future.’/ ‘I am committed to engaging in
behaviours that protect me against getting cancer in the
future.’ / ‘I fully intend to have a lifestyle that will pre-
vent me from getting cancer in the future.’ / ‘I will try to
do all I can to avoid getting cancer in the future.’).
Intention to change for each of the seven key lifestyle
behaviours will also be asked separately using one item
for each (e.g. ‘I intend to be more physically active in the
next three months’) on a 5-point Likert response scale
from 1 (Strongly disagree) to 5 (Strongly agree) with a
sixth option ‘Not applicable’. Response efficacy and
self-efficacy will both be measured using three items for
physical activity and three items for diet as used in pre-
vious research [49, 50].
Self-rated health, family history of cancer, numeracy
and time orientation will also be measured at baseline.
Numeracy will be assessed using the 3-item Schwartz
scale [51] adapted for the UK. Time orientation, the ex-
tent to which individuals tend to be motivated more by
future or present goals when making decisions, will be
measured using the brief nine item form of the Zimbardo
Time Perspective Inventory (ZTPI-R) [52] which includes
measures of both present and future orientation. We will
also collect data on ethnicity and educational level in
order to describe the cohort in comparison to the UK
population.
Participants’ views of the risk and/or lifestyle informa-
tion will also be assessed immediately post intervention
by asking participants how much they agreed that the
interventions were understandable, trustworthy, useful,
motivating, important and well-presented and helped
them decide about cancer risk reduction [53]. We will
also collect process measures to assess how participants
used the intervention using website analytics. These will
include the total time spent on the intervention, the
time spent viewing the risk information, the number of
times participants set target values and view the effect of
those changes on the estimates of risk, which lifestyle
pages are viewed, and whether participants enter any
specific behavioural goals.
Statistical analyses
Univariate descriptive statistics (means and standard de-
viations or medians and interquartile ranges, numbers,
and percentages) will be used to summarise participant
characteristics at baseline overall and by randomised
group and check for skewed distributions. All trial ana-
lyses will be performed including participants in the
groups to which they were randomised (based on the
intention-to-treat principle), but excluding individuals
with missing outcome data.
For the primary outcome, intervention effects will be
estimated using a linear regression model of change in
risk relative to an individual with a recommended life-
style (risk at three months follow-up minus risk at base-
line), with the baseline value included as a covariate in
the model (i.e. analysis of covariance, ANCOVA). The
missing indicator method [54] will be used to enable in-
dividuals with missing values of the outcome at baseline
to be included. An F-test will be performed of the null
hypothesis that there is no difference between the four
randomised groups. The model will also be used to de-
rive estimates and confidence intervals from four pair-
wise comparisons: 1) Control group vs the three risk
groups combined; 2) bar chart risk presentation vs picto-
graphs; 3) bar chart risk presentation vs qualitative scale;
and 4) pictographs vs qualitative scale. Multiplicative
interactions between the interventions and each of the
following variables will be tested using an F-test: age (≤
or > 40 years), sex, baseline risk relative to an individual
with a recommended lifestyle (≤ or > 1.5), self-perceived
risk at baseline below or above estimated risk or numer-
acy (< or ≥ two correct answers). If the p-value for inter-
action with one of the above variables is < 0.05, then
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estimates and confidence intervals for each of the pair-
wise comparisons will be derived within each subgroup
defined by that variable.
Similar analyses will be used to estimate intervention
effects on continuous secondary outcome variables.
Smoking status (current vs ex-smoker and non-smoker)
and accuracy (correct/incorrect) at three months
follow-up will be analysed using binary logistic regres-
sion models, with adjustment for their respective values
at baseline; randomised groups will be compared using a
likelihood ratio test, and the four pairwise differences
(risk ratios) and confidence intervals will be estimated.
Intention to change behaviour, self-efficacy and response
efficacy are only measured immediately after the inter-
vention so linear regression will be used.
For all outcomes, 98.75% confidence intervals will be
presented (based on a Bonferroni corrected significance
threshold of 1.25%) to acknowledge the fact that four
pairwise comparisons are presented. For any particular
outcome, this is a conservative approach since the com-
parisons are not all independent of each other.
Acceptability, usefulness of the risk and/or lifestyle in-
formation, and process measures relating to use of the
intervention will be summarised across the four groups
using descriptive statistics (means, standard deviations,
numbers, and percentages).
Sample size
The target sample size is 1000 participants (250 per
group). In the EPIC-Norfolk cohort [54] the mean risk
of developing one or more of the five chosen cancers
relative to an individual with a recommended lifestyle
is 1.77 (SD 0.97). It is likely that the baseline and
follow-up values of the outcome will be correlated, but
the size of this correlation is unknown. To detect a
baseline-adjusted between-group difference of 0.3 with
a significance level of 1.25%, assuming the SD is 0.97
and 10% loss to follow-up, the power will be 79, 80% or
83% if the correlation is assumed to be 0.1, 0.2 or 0.3.
Patient and public involvement (PPI)
Two patient and public representatives have been in-
volved in the design of this trial. In particular, they have
commented on the questionnaires and the wording and
format of the presentation of the risk estimates, critically
revised participant information sheets, and contributed
to the development of the web-based lifestyle interven-
tion. We expect that they will also be involved with de-
veloping newsletters and taking part in dissemination
activities.
Data management
Each participant is assigned a unique numeric identifier
by Prolific so that no personal information is released to
researchers. No personally identifiable data will be col-
lected during the trial. All data will be held in accord-
ance with the University of Cambridge Primary Care
Unit policy on data security and confidentiality regula-
tions will be strictly adhered to.
Ethics
This trial is sponsored by the School of Clinical Medi-
cine at the University of Cambridge. Ethical approval
was received from the Psychology Research Ethics com-
mittee of the University of Cambridge on 12 December
2017 (Ref: PRE.2017.093). The trial was prospectively
registered at the ISRCTN Registry (ISRCTN17450583)
on 30 January 2018.
Data monitoring
A data monitoring committee is not considered appro-
priate for this trial given the low-risk nature and the
short period of time between recruitment and follow-up.
The data are also both collected and stored online, so
there are no risks in relation to data entry. The trial
management committee, comprising the research team,
will monitor the progress of the trial and ensure it runs
in accordance with the protocol, oversee day-to-day
management of the study and compliance with the De-
partment of Health Research Governance Framework
and the Guidelines for Good Clinical Practice. It will be
also be responsible for communicating important proto-
col modifications to the sponsor, research ethics com-
mittee and ISRCTN registry.
Dissemination
This trial is embedded within a larger programme of re-
search developing and evaluating Interventions for
Cancer Prevention in Primary Care (the I-CaPP pro-
gramme).We plan to submit the findings of this trial to
an open-access peer-reviewed journal and present the
findings at national and international conferences. We
will also send a summary of the findings to all partici-
pants and provide a summary on the I-CaPP website
(http://www.phpc.cam.ac.uk/pcu/i-capp/).
Discussion
This trial will provide much needed evidence of the
short-term effects of communicating information about
personalised risk of the five most common preventable
cancers on risk-reducing health behaviours. It will also,
to our knowledge, be the first to use the Tripartite
model of risk perception in a UK population and the
first to measure risk conviction both before and after
provision of risk information.
The use of an integrated web-based platform to both
deliver the intervention and collect data will also allow
us to track the time spent on each page, the target values
Usher-Smith et al. BMC Public Health  (2018) 18:796 Page 8 of 10
set, and individual participants’ routes through the inter-
vention. While we do not plan a per protocol analysis
because it is not possible for participants to proceed
without viewing the risk information and setting targets,
this will allow us to measure engagement with the inter-
vention in detail [55] and explore which elements were
used most by participants.
However, the chosen recruitment method, although
enabling rapid recruitment of a large sample size, will in-
evitably limit generalisability due to the specific demo-
graphics of Prolific members. 72% of Prolific members
are aged 20–40 years, 79% are Caucasian and 63% have
A level or degree qualifications [56]. In addition mem-
bers are seasoned research participants with experience
of completing a variety of online tasks, and as such their
computer literacy and aptitude for completing such tasks
is likely to be above average compared to the general
population [57].
Nevertheless, the findings of this trial have the poten-
tial to inform future work on development of risk-based
interventions for cancer and guide the use of cancer risk
scores online and within primary care.
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